Richard Bruce Sparks

This inventor holds 10 USPTO granted patents. Top assignees: Zeneca Limited, Imperial Chemical Industries Limited. Active years: 1997-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Bruce Sparks. Retrieved from https://idiyas.com/inventor/richard-bruce-sparks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 40(Granted Patents)

Location History:

Boothwyn, PA (US) (2001)
Linwood, PA (US) (1997 - 2004)

Company Filing History:

Imperial Chemical Industries Limited

patents

Years Active: 1997-2004

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6737424 - Alpha-substituted pyridazino quinoline compounds (2004-05-18),

2. 6232313 - Pyridazino quinoline compounds (2001-05-15),

3. 6214826 - Pyridazino quinoline compounds (2001-04-10),

4. 6103721 - Heteroaryl-substituted pyridazino quinoline compounds (2000-08-15),

5. 5837705 - Alpha-substituted pyridazino quinoline compounds (1998-11-17),

6. 5744471 - Pyridazion quinoline compounds (1998-04-28),

7. 5739133 - Pyridazinedione compounds useful in treating neurological disorders (1998-04-14),

8. 5733910 - Pyridazinedione compounds useful in the treating neurological disorders (1998-03-31),

9. 5604227 - Pyridazinedione compounds useful in treating neurological disorders (1997-02-18),

10. 5599814 - Pyridazinedione compounds useful in treating neurological disorders (1997-02-04),

Title: The Innovative Journey of Richard Bruce Sparks

Introduction

Richard Bruce Sparks, an esteemed inventor based in Linwood, Pennsylvania, has made significant contributions to the field of chemistry and pharmaceuticals. With a remarkable portfolio of ten patents, Sparks is recognized for his innovative approaches to developing new compounds that advance medical science.

Latest Patents

Sparks' latest patents include innovative formulations such as Alpha-substituted pyridazino quinoline compounds and pyridazino quinoline compounds. These patents encompass novel compounds, pharmaceutical compositions, and methods for utilizing these compounds, reflecting his commitment to enhancing therapeutic options.

Career Highlights

Throughout his career, Richard Sparks has been associated with prominent companies, including Zeneca Limited and Imperial Chemical Industries Limited. His work in these organizations has allowed him to push the boundaries of pharmaceutical research and development, showcasing his expertise in creating valuable innovations.

Collaborations

Sparks has collaborated with notable colleagues like Thomas Michael Bare and James Roy Empfield, contributing to a dynamic teamwork environment that fosters creativity and progress in invention. These partnerships have been instrumental in driving success and bringing cutting-edge ideas to fruition.

Conclusion

Richard Bruce Sparks stands as a beacon of innovation in the pharmaceutical industry. His extensive patent portfolio and noteworthy collaborations reflect his dedication to advancing science. As he continues to explore new frontiers in research, Sparks’ impact on the field will undoubtedly resonate for years to come.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]